UFABC patents KLK7 antibodies, skin desquamation, 31st Mar
Summary
UFABC patents KLK7 antibodies, skin desquamation, 31st Mar
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Recombinant human antibodies that inhibit the human tissue kallikrein 7 (KLK7) and their use against diseases that cause desquamation of the skin
Grant US12590170B2 Kind: B2 Mar 31, 2026
Assignee
Fundação Universidade Federal do ABC—UFABC
Inventors
Luciano Puzer, Ana Flávia Santarine Laureano, Daniele Ribeiro De Araújo, Michael Hust
Abstract
The present invention relates to human tissue kallikrein 7 (KLK7) selective inhibitor compounds, combinations including these compounds, process to obtain the referred compounds, and methods of using the same. The present invention belongs to the field of chemistry, pharmacology and medicine.
CPC Classifications
C07K 16/40 A61K 9/0014 A61K 9/06 A61K 47/34
Filing Date
2021-05-14
Application No.
17925061
Claims
15
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.